TickerFactsScreenerDevelopers

GOLDENWELL BIOTECH, INC. (GWLL) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2018: $02019: $246.6K2020: $248.6K2021: $213.6K2022: $46.0K$46.0K
2018Cash & Equivalents (USD)2022
Fiscal YearCash & EquivalentsChange YoY
2022$46.0K-78.5%
2021$213.6K-14.1%
2020$248.6K+0.8%
2019$246.6K—
2018$0—